Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Tolusso

Showing results (61-70 of 94) with videos related to

Pageof 10
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 1, 2025
Nonmedical switch of anti-TNF-α biosimilars has no major clinical, pharmacokinetic and psychological impact on patients with IBD - the SAFER StudyGiuseppe Privitera, Lucia Monastero, Elena Melita, et al.
Rheumatology (Oxford, England)|January 11, 2014
Body weight, gender and response to TNF-α blockers in axial spondyloarthritisElisa Gremese, Simone Bernardi, Sara Bonazza, et al.
Plos One|June 12, 2014
Toll-like receptor 4 mediates endothelial cell activation through NF-κB but is not associated with endothelial dysfunction in patients with rheumatoid arthritisRossella Menghini, Umberto Campia, Manfredi Tesauro, et al.
Frontiers in Medicine|November 16, 2020
Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination TherapiesLuca Petricca, Maria Rita Gigante, Annamaria Paglionico, et al.
Frontiers in Medicine|July 19, 2018
Synovial Predictors of Differentiation to Definite Arthritis in Patients With Seronegative Undifferentiated Peripheral Inflammatory Arthritis: microRNA Signature, Histological, and Ultrasound FeaturesStefano Alivernini, Barbara Tolusso, Luca Petricca, et al.
Frontiers in Medicine|September 13, 2021
Depression and Endothelial Dysfunction in Psoriatic Arthritis: Is There Any Possible Relationship?Enrico De Lorenzis, Angela Di Giorgio, Gerlando Natalello, et al.
Plos One|August 4, 2012
Biomarkers of good EULAR response to the B cell depletion therapy in all seropositive rheumatoid arthritis patients: clues for the pathogenesisGianfranco Ferraccioli, Barbara Tolusso, Francesca Bobbio-Pallavicini, et al.
Annals of Laboratory Medicine|October 26, 2019
Laboratory Monitoring of Biological Therapies in Rheumatology: The Role of ImmunogenicityMaurizio Benucci, Valentina Grossi, Mariangela Manfredi, et al.
Arthritis Research & Therapy|December 15, 2016
Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritisJérémie Sellam, Elodie Rivière, Alice Courties, et al.
Annals of the Rheumatic Diseases|February 2, 2012
Polymorphisms of the IgH enhancer HS1.2 and risk of systemic lupus erythematosusDomenico Frezza, Barbara Tolusso, Vincenzo Giambra, et al.
Pageof 10

Showing results (61-70 of 94) with videos related to

Sort By:
Pageof 10
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 1, 2025
Nonmedical switch of anti-TNF-α biosimilars has no major clinical, pharmacokinetic and psychological impact on patients with IBD - the SAFER StudyGiuseppe Privitera, Lucia Monastero, Elena Melita, et al.
Rheumatology (Oxford, England)|January 11, 2014
Body weight, gender and response to TNF-α blockers in axial spondyloarthritisElisa Gremese, Simone Bernardi, Sara Bonazza, et al.
Plos One|June 12, 2014
Toll-like receptor 4 mediates endothelial cell activation through NF-κB but is not associated with endothelial dysfunction in patients with rheumatoid arthritisRossella Menghini, Umberto Campia, Manfredi Tesauro, et al.
Frontiers in Medicine|November 16, 2020
Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination TherapiesLuca Petricca, Maria Rita Gigante, Annamaria Paglionico, et al.
Frontiers in Medicine|July 19, 2018
Synovial Predictors of Differentiation to Definite Arthritis in Patients With Seronegative Undifferentiated Peripheral Inflammatory Arthritis: microRNA Signature, Histological, and Ultrasound FeaturesStefano Alivernini, Barbara Tolusso, Luca Petricca, et al.
Frontiers in Medicine|September 13, 2021
Depression and Endothelial Dysfunction in Psoriatic Arthritis: Is There Any Possible Relationship?Enrico De Lorenzis, Angela Di Giorgio, Gerlando Natalello, et al.
Plos One|August 4, 2012
Biomarkers of good EULAR response to the B cell depletion therapy in all seropositive rheumatoid arthritis patients: clues for the pathogenesisGianfranco Ferraccioli, Barbara Tolusso, Francesca Bobbio-Pallavicini, et al.
Annals of Laboratory Medicine|October 26, 2019
Laboratory Monitoring of Biological Therapies in Rheumatology: The Role of ImmunogenicityMaurizio Benucci, Valentina Grossi, Mariangela Manfredi, et al.
Arthritis Research & Therapy|December 15, 2016
Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritisJérémie Sellam, Elodie Rivière, Alice Courties, et al.
Annals of the Rheumatic Diseases|February 2, 2012
Polymorphisms of the IgH enhancer HS1.2 and risk of systemic lupus erythematosusDomenico Frezza, Barbara Tolusso, Vincenzo Giambra, et al.
Pageof 10